Abstract

Introduction: Community health centers (CHCs) provide care to a disproportionate share of vulnerable populations who are at highest risk for uncontrolled hypertension. It is unknown how hypertension treatment at CHCs reflects guideline-concordant therapy compared to private practice. Methods: We used the National Ambulatory Medical Care Surveys (NAMCS) from 2006 to 2010 to examine four guideline-concordant treatment practices in non-pregnant adults with hypertension: Initiation of a new medication for uncontrolled hypertension, use of fixed-dose combination drugs for patients on multiple antihypertensive medications, use of thiazide diuretics among patients with uncontrolled hypertension on ≥3 antihypertensive medications, and use of aldosterone antagonist for resistant hypertension, comparing use at CHCs to private physician’s offices overall and by payer group. Results: Medicaid patients at CHCs were as likely as privately insured individuals to receive a new medication for uncontrolled hypertension (AOR 1.0, 95% CI 0.6-1.9), while Medicaid patients at private physicians’ offices were less likely to receive a new medication compared to the privately insured (AOR 0.3, 95% CI 0.1-0.6). Use of fixed-dose combination drugs was lower at CHCs (AOR 0.6, 95% CI 0.4 – 0.9). There was no difference in thiazide use (adjusted OR 0.7, 95% CI 0.4 – 1.5). Aldosterone antagonist use in resistant hypertension was extremely low in both settings (< 3%). Conclusion: Compared to private practice, CHCs are more likely to intensify hypertension treatment for patients with Medicaid but less likely to use fixed-dose combination drugs for patients taking multiple medications. Increasing physician use of fixed-dose combination drugs may be particularly helpful in improving hypertension control at CHCs where there are higher rates of uncontrolled hypertension.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call